C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2004
12/23/2004	CA2528382A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them
12/23/2004	CA2527832A1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
12/23/2004	CA2527773A1 Cycloalkanepyrrolopyridines as dp receptor antagonists
12/23/2004	CA2527236A1 Thiotungstate analogues and uses thereof
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/22/2004	EP1489155A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
12/22/2004	EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1487836A1 Ethane-1,2-diamino-bis (2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
12/22/2004	EP1487833A1 Process for preparing a pharmaceutically active compound (granisetron)
12/22/2004	EP1487822A2 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487803A1 Indazoles substituted with an anti-cancerous activity
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487486A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
12/22/2004	EP1487450A1 Process for the preparation of antiviral 7-azaindole derivatives
12/22/2004	EP1487441A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
12/22/2004	EP1436266A4 Methods and compositions of novel triazine compounds
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1282732A4 Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems
12/22/2004	EP1140090B1 Use of phanquinone for the treatment or prevention of memory impairment
12/22/2004	EP1121363B1 6-SUBSTITUTED PYRAZOLO(3,4-d)PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
12/22/2004	EP0997462B1 Novel naphthyridine derivatives or salts thereof
12/22/2004	EP0987254B1 Novel cyclic diamine compounds and medicine containing the same
12/22/2004	CN1556705A 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
12/22/2004	CN1181075C Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
12/22/2004	CN1181073C Method for producing triethylene diamine using ethylene diamine
12/22/2004	CN1181071C Tetra-(1,4,8,9-tetraaza) benzophenanthrene metal-phthalocyanine compound and its synthesizing process
12/22/2004	CN1181070C Urea substituted imidazoquinolines
12/22/2004	CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/21/2004	US6833384 Deacetylase inhibitors
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833372 A hormone inhibitors of gonadotropin releasing hormone, an antigonadotropins, new drug compound contains a furanyl 2-carboxylic acid -(2,4-dimethoxy-pyrimidin-5-yl)-amide groups
12/21/2004	US6833368 Tackykinin antagonist
12/21/2004	US6833364 Inhibiting degradation of cyclic guanosine monophosphate; cardiovascular disorders; such as 3-(4-amino-5-cyclopropyl-pyrimidin-2-yl)-1-(2-fluorobenzyl)1H-pyrazolo-(3,4 -b)-pyridine
12/21/2004	US6833202 Electroluminescent devices
12/21/2004	CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/16/2004	WO2004108725A1 Preparation of substituted quinoxalines from the dianline with 2,3-dihydroxy-1,4-dioxane
12/16/2004	WO2004108724A1 Tricyclic compound
12/16/2004	WO2004108723A1 4,5-dihydro-imidazo[4,5,1-ii]quinolin-6-ones as parp inhibitors
12/16/2004	WO2004108722A1 Orthocondensed polycyclic aminopyrrole derivatives comprising an electro-attractive substituent, combination products of said derivatives, and method for the production thereof
12/16/2004	WO2004108702A1 Indole derivatives with apoptosis-inducing effect
12/16/2004	WO2004108215A1 Piperidinyl prostaglandin e analogs
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004096805A9 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles
12/16/2004	WO2004076449A3 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254372 Poly(adenosine 5'-diphospho-ribose)polymerase (PARP) inhibitor; for treating or preventing neurological, genetic, autoimmune, nervous system, cardiovascular disorders, cancer; such as myocardial infarction, angina pectoris and cardiogenic shock
12/16/2004	US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/16/2004	US20040254211 Alpha v integrin receptor antagonists
12/16/2004	US20040254205 Phenalene derivatives
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254199 For plants, animals; nematocides
12/16/2004	US20040254191 Antiinflammatory agents; autoimmune diseases; controlling tumor necrosis factor; immunosuppressants
12/16/2004	US20040254163 New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
12/16/2004	US20040254158 1,1-Disubstituted cycloalkyl derivatives as factor Xa inhibitors
12/16/2004	DE10323345A1 Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren New Pyridopyrazine and their use as kinase inhibitors
12/16/2004	CA2528497A1 Tricyclic compound
12/16/2004	CA2528179A1 Piperidinyl prostaglandin e analogs
12/16/2004	CA2527337A1 Preparation of substituted quinoxalines from the dianline with 2,3-dihydroxy-1,4-dioxane
12/16/2004	CA2524376A1 Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands
12/15/2004	EP1486550A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
12/15/2004	EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
12/15/2004	EP1485383A1 Process for preparing crystalline form i of cabergoline
12/15/2004	EP1485382A2 Process for the synthesis of pergolide
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485376A1 Compositions useful as inhibitors of protein kinases
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485093A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
12/15/2004	EP1485086A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as nmda, 5ht3, and neuronal nicotinic receptor antagonists
12/15/2004	EP1399155A4 Small molecules useful in the treatment of inflammatory disease
12/15/2004	EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
12/15/2004	EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof
12/15/2004	EP1218005B1 Vitronectin receptor antagonists
12/15/2004	EP0900796B1 Preventives and remedies for ischemic intestinal lesion and ileus
12/15/2004	CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives
12/15/2004	CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier
12/15/2004	CN1554343A Compounds for treating fibromyalgia and chronic fatigue syndrome
12/15/2004	CN1554341A Compounds for treating fibromyalgia and chronic fatigue syndrome
12/15/2004	CN1179962C Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient
12/14/2004	US6831175 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine
12/14/2004	US6831074 Inhibitors of cyclic guanosine 3',5'-monophosphate phosphodiesterases (cGMP PDES); for use in therapy of sexual disorders
12/14/2004	US6831061 Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them
12/14/2004	US6830836 Heterocyclic compounds, materials for light emitting devices and light emitting devices using the same
12/14/2004	CA2235146C Herbicidal sulfonamides
12/14/2004	CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom
12/14/2004	CA2136075C Heterocyclic ether compounds that enhance cognitive function
12/09/2004	WO2004106493A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
12/09/2004	WO2004106336A1 Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides
12/09/2004	WO2004106335A1 Harmine derivatives, intermediates used in their preparation, preparation processes and use thereof
12/09/2004	WO2004106334A2 Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation
12/09/2004	WO2004106308A1 Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors

1 ... 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 ... 646